Objective: To test the hypothesis of an inverse association between indicators of vascular disease and cognitive function in the general, stroke free population.
Introduction
Research into cognitive function in prospective cohort studies reveals that it is likely that there are multiple determinants of cognitive decline. Besides age, the other two factors most widely implicated in cognitive decline are pathology and socioeconomic factors. 1 Recent evidence suggests that vascular risk factors (such as hypertension, diabetes mellitus, cholesterol level, fibrinogen level) and indicators of vascular disease are associated with both cognitive impairment [2] [3] [4] [5] [6] [7] and dementia. [8] [9] [10] In the research literature a distinction is made between vascular and non-vascular dementia, [11] [12] based on establishing a temporal connection between vascular disease and decline in cognitive functioning in the case of vascular dementia. However, the generalized association between vascular disease and poor cognitive function suggests that the atherosclerotic process and related hypoperfusion may be causally linked to both vascular and non-vascular dementia. 9 Our paper aims to provide further evidence for the link between vascular disease and cognitive function in a sample of middle aged individuals, undiagnosed of dementia. We wish to test whether the presence of vascular disease is predictive of poor cognitive function, even in a functioning, healthy group of individuals. By using indicators of peripheral vascular disease and coronary heart disease as measures of generalized atherosclerosis, we hypothesize that these might act as surrogate measures of cerobrovascular disease and will be related to impaired cognitive function. As there is some evidence suggesting that memory loss may not always be associated with cognitive impairment due to vascular causes, [13] [14] we will examine a wide range of measures of cognitive function. 4 
Participants and Methods

Participants
The Whitehall II study was established in 1985 as a longitudinal study to examine the socioeconomic gradient in health and disease among 10,308 non-industrial civil servants (6,895 men and 3,413 women). 15 Subjects were asked to recall in writing as many words beginning with "S" and as many animal names as they could. One minute was allowed for each test.
Statistical methods
As it is widely accepted that stroke has an adverse effect on cognitive function, [19] [20] all participants who had a stroke by Phase 5 of data collection were excluded from our analyses.
Four (one for each disease measure) X 2 (vascular disease, no vascular disease) X 2 (men, women) between-subjects MANCOVA were performed on 6 outcome measures of cognitive function. As the outcome measures (different tests of cognitive function) are correlated with
each other we preferred to analyze data using MANCOVA rather than ANCOVA.
Adjustment was made for two covariates: age and employment grade. Other covariates considered were cardiovascular risk factors such as hypertension, cholesterol, and cigarette smoking. However, the patterning and magnitude of the association between vascular disease and cognitive function was the same prior to and after adjustment for these cardiovascular risk factors. In light of this, we report results adjusted for age and employment grade alone. A full-7 factorial model was tested for each measure of vascular disease, allowing the predictor variables to interact. The effects of the predictor variables on the outcome variables after adjustment for covariates was further investigated in univariate analysis to check for cognitive impairment in selective domains.
In order to assess the impact of a significant main effect on individual outcome variables, each measure of cognitive function was assessed using a univariate F test at p<0.05.
For statistically significant effects, the difference between means was expressed as an effect size. The measure of effect size used here is Cohen's d where the difference between means is expressed as a proportion of the standard deviation for that test. 21 The advantage of expressing mean differences this way is that it allows comparison of effects across the various tests of cognitive function. The convention is to regard effect sizes of "d=.2" as "small", "d=.5" as "medium", "d=.8" as "large".
Results
Missing data
The Whitehall II study, established between 1985 and 1988 had a total of 10,308 civil servants at Phase 1 of data collection (see Table1 ) Table 2 . The table shows the adjusted mean scores on the cognitive function tests. The means have been adjusted for the effects of age and socioeconomic position, with statistically significant differences further expressed as an effect size.
The presence of angina between was associated with poorer cognitive function at phase 5 in both men and women (F(6, 5680) = 5.16, p<.001, Table 2 ). Angina was associated with poor cognitive function on all tests, although the effect sizes were small -average .21 for men and .24 for women. Non-fatal myocardial infarction (MI) was associated with poor cognitive function but univariate analysis revealed that this effect was not significant for all tests of cognitive function (F(6, 5535) = 2.56, p<.02, Table 2 ). There was no influence of non-9 fatal MI on memory, numerical reasoning and phonemic fluency. However, there was a significant association between presence of MI and verbal reasoning, Mill Hill and semantic fluency with an average effect size of .23 for men and .22 for women.
There was a comprehensive association between all CHD (MI and angina) and cognitive function for both men and women (F(6, 5747) = 4.80, p<.001, Table 2 ). Individuals with heart disease had poorer scores on all cognitive tests, with the average effect sizes being .21 for men and .15 for women. Respondents reporting a diagnosis of intermittent claudication (IC) were also found to have poorer cognitive function (F(6, 5418) = 3.23, p=.004). As is evident from Table 2 , there was an interaction between IC and sex for measures of memory and semantic fluency. IC was associated with memory impairment and poor semantic fluency in men but not in women. The average effect size for IC was .41 for men and .25 for women.
Sex and cognitive function
As sex had a significant main effect in the analyses examining the associations between vascular disease and cognitive function a separate MANCOVA was run to examine the main effect of sex. As is evident from Table 3 there was a significant effect of sex on cognitive function. The effect was due to men doing better at the numerical component of the AH 4 (p<0.001) and at Mill Hill (p<0.02). Women scored better on the memory test (p<0.001) and the verbal fluency tests -both phonemic (p<0.001) and semantic fluency (p<0.001). Research shows that the link between vascular pathology and cognitive impairment is particularly acute in women amongst the very old. 22 However, our results do not show this to be the case in a relatively young sample.
Discussion
We investigated the association between indicators of vascular disease and cognitive function in a large, stroke free, UK cohort. Three key results from this study need to be Second, there was little specificity in this association as all areas of cognitive function examined were found to be affected by indicators of vascular pathology. There has been some evidence to suggest that memory is not always affected by vascular disease, [13] [14] 20 , 25 but we found that in this healthy, relatively young sample that is not the case. MI was the only condition where memory was not affected, but then the effect of MI was more selective (see Table 2 ) than the other indicators of vascular disease. Other studies have also found the link between MI and poor cognitive performance to be tenuous. 26 We found larger effects for 11 intermittent claudication, arguably the more accurate marker of chronic vascular disease.
Weaker effects were found for myocardial infarction and all coronary heart disease which are likely to include processes other than generalized vascular impairment.
The debate on specificity of cognitive impairment is linked to the relationship between cognitive impairment and dementia. 20 Defective memory and orientation are the hallmarks of dementia. 27 The results from this study suggest that vascular pathology is linked to global cognitive impairment, including domains that are key to the diagnosis of dementia. At the population level cognitive impairment is frequently examined using the Mini-Mental State Examination (MMSE). However, as the MMSE has ceiling effects among younger nondemented populations 28 it would not have been suitable for this population. The battery of tests that we used allowed an examination of different aspects of cognitive function rather than dementia per se.
Finally, there were no significant interactions between age and vascular disease, nor between employment grade and vascular disease. This implies that the negative effects of vascular disease did not vary by age or by employment grade. In a slightly older, AfricanCaribbean population, some vascular risk factors were found to be associated with poorer cognitive function only in those with lower levels of education. 29 
Public health implications
Cognitive impairment has been shown to be a predictor of functional decline, 20 dependent living, 20 and mortality. 3 The significance of the results reported here is that vascular pathology is predictive of poor cognitive function relatively early, and the ensuing functional decline and dementia dictate that efforts be made to alter the sequence of events.
There is some evidence to suggest that antithrombotic medication may protect cognitive function in men with cardiovascular disease. 30 Consequently, the public health implications are in the domain of more aggressive management of vascular risk factors and vascular 12 disease even in stroke free populations. There may be additional benefits from treatment if it also slows down the process of cognitive decline and therefore should become more widespread.
Limitations of study
Some limitations of the current study should be noted. Firstly, the indicators of vascular disease used in this study are only proxy markers of cerebral circulation and cerebro-vascular disease. Stronger associations may be found if better measures of vascular disease were used.
Secondly, the findings reported here are based on a single measure of cognitive function.
With repeated measures of the cognitive tests it will be possible to explore changes in function in relation to vascular disease. Finally, it is likely that the strength of association between vascular disease and cognitive impairment has been underestimated in this study due to missing data. Apart from the reported biases relating to low socioeconomic position and poor cognitive function, it is likely that loss to follow-up is also influenced by poor health. 
